{
  "docId": "019de515-df71-7068-a98d-cc2a99c8892d",
  "docSlug": "c88233ba648814c9f5b65afc1926df6d",
  "documentTitle": "Adagio Therapeutics | Investor Conference Presentation Deck | 11 slides",
  "authorId": "adagio-therapeutics",
  "authorName": "Invivyd",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 11,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-df71-7068-a98d-cc2a99c8892d/7",
  "deckHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d",
  "deckJsonHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d.json",
  "deckAnchorHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.54,
        "w": 0.602,
        "x": 0.176,
        "y": 0.349
      },
      "kind": "chart",
      "text": "TOTAL REVENUE (MILLIONS)\n$1,400\n$1,270M\n$1,200\n$1,000\n$800\n$600\n$400\n$200\n$0\nH2 2021\nH1 2022\nH2 2022\n841% growth\n$914M\n$135M",
      "attrs": {
        "x_axis_label": "Period",
        "y_axis_label": "TOTAL REVENUE (MILLIONS)"
      },
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d05c51bf-c4c3-432f-bd96-5b498a347a02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.014,
        "w": 0.296,
        "x": 0.034,
        "y": 0.954
      },
      "kind": "source-note",
      "text": "Sources: Results publicly reported by AstraZeneca.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ed617c5-e696-4a54-bcb3-3094d43b92c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.653,
        "x": 0.176,
        "y": 0.24
      },
      "kind": "title",
      "text": "$2.2B in total revenue of Evusheld® in 2022, a mAb previously authorized to protect vulnerable populations from COVID-19",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "833943f5-9f52-4a0b-b1e0-2881e92d3f8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.089,
        "w": 0.899,
        "x": 0.046,
        "y": 0.079
      },
      "kind": "title",
      "text": "WE BELIEVE PREVENTION OF COVID-19 IN VULNERABLE POPULATIONS IS A LONG-TERM, POTENTIALLY LARGE OPPORTUNITY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "246a347d-d04c-4ff8-8745-ae7ad2ccc578",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 7,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "3b35d58f-2d99-44a5-b484-2bf12410ffb9",
      "evidence": "Slides 7-10 discuss market sizing, ongoing trials, and proposed solutions.",
      "position": 1,
      "objective": "How can Invivyd's VYD222 address the unmet need?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}